These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16076502)

  • 1. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
    Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
    Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory efficacy of cyclosal-nucleoside monophosphates of aciclovir and brivudin on DNA synthesis of orthopoxvi ruses.
    Sauerbrei A; Meier C; Meerbach A; Wutzler P
    Antivir Chem Chemother; 2006; 17(1):25-31. PubMed ID: 16542003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
    Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
    Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV.
    Meerbach A; Klöcking R; Meier C; Lomp A; Helbig B; Wutzler P
    Antiviral Res; 2000 Jan; 45(1):69-77. PubMed ID: 10774591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
    Balzarini J; Haller-Meier F; De Clercq E; Meier C
    Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry and anti-herpes simplex virus type 1 evaluation of cycloSal-nucleotides of acyclic nucleoside analogues.
    Meier C; Habel L; Haller-Meier F; Lomp A; Herderich M; Klöcking R; Meerbach A; Wutzler P
    Antivir Chem Chemother; 1998 Sep; 9(5):389-402. PubMed ID: 9875392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
    Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
    Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pyrimidine-pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity.
    Fan X; Zhang X; Zhou L; Keith KA; Kern ER; Torrence PF
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3224-8. PubMed ID: 16603351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
    Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
    Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study.
    Williams DL; Fitzmaurice T; Lay L; Forster K; Hefford J; Budge C; Blackmore K; Robinson JC; Field HF
    Curr Eye Res; 2004; 29(2-3):215-8. PubMed ID: 15512970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents.
    Pirrung MC; Pansare SV; Sarma KD; Keith KA; Kern ER
    J Med Chem; 2005 Apr; 48(8):3045-50. PubMed ID: 15828843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
    Hussein IT; Menashy RV; Field HJ
    Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 4',4'-difluoro analog of 5'-noraristeromycin: a new structural prototype for possible antiviral drug development toward orthopoxvirus and cytomegalovirus.
    Roy A; Schneller SW; Keith KA; Hartline CB; Kern ER
    Bioorg Med Chem; 2005 Jul; 13(14):4443-9. PubMed ID: 15908221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
    Meier C; Knispel T; Marquez VE; Siddiqui MA; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1615-24. PubMed ID: 10229630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture.
    Reis SA; Moussatché N; Damaso CR
    J Appl Microbiol; 2006 Jun; 100(6):1373-80. PubMed ID: 16696686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
    Meier C; Knispel T; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and antiherpes activity of acyclovir phosphoesters].
    Galegov GA; Shobukhov VM; Leont'eva NA; Ias'ko MV
    Bioorg Khim; 1997 Nov; 23(11):906-9. PubMed ID: 9518431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell metabolism of acyclovir phosphonate derivatives and antiherpesvirus activity of their combinations with alpha2-interferon.
    Skoblov YS; Karpenko IL; Jasko MV; Kukhanova MK; Andronova VL; Galegov GA; Sidorov GV; Myasoedov NF
    Chem Biol Drug Des; 2007 Jun; 69(6):429-34. PubMed ID: 17581237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.